227 related articles for article (PubMed ID: 33768245)
1. Opening of ATP sensitive potassium channels causes migraine attacks with aura.
Al-Karagholi MA; Ghanizada H; Nielsen CAW; Hougaard A; Ashina M
Brain; 2021 Sep; 144(8):2322-2332. PubMed ID: 33768245
[TBL] [Abstract][Full Text] [Related]
2. Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine.
Al-Karagholi MA; Hansen JM; Guo S; Olesen J; Ashina M
Brain; 2019 Sep; 142(9):2644-2654. PubMed ID: 31292608
[TBL] [Abstract][Full Text] [Related]
3. Effect of K
Al-Karagholi MA; Ghanizada H; Kokoti L; Paulsen JS; Hansen JM; Ashina M
Cephalalgia; 2020 Sep; 40(10):1045-1054. PubMed ID: 32806954
[TBL] [Abstract][Full Text] [Related]
4. Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial.
Raffaelli B; Do TP; Chaudhry BA; Amin FM; Ashina H; Snellman J; Maio-Twofoot T; Ashina M
Cephalalgia; 2024 Jan; 44(1):3331024231222916. PubMed ID: 38181724
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache.
Al-Khazali HM; Christensen RH; Dodick DW; Chaudhry BA; Burstein R; Ashina H
Cephalalgia; 2023 Nov; 43(11):3331024231210930. PubMed ID: 37917826
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial.
Kokoti L; Al-Karagholi MA; Waldorff Nielsen CA; Ashina M
Neurotherapeutics; 2023 Mar; 20(2):389-398. PubMed ID: 36763326
[TBL] [Abstract][Full Text] [Related]
7. Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trial.
Al-Khazali HM; Deligianni CI; Pellesi L; Al-Karagholi MA; Ashina H; Chaudhry BA; Petersen AS; Jensen RH; Amin FM; Ashina M
Pain; 2024 Jun; 165(6):1289-1303. PubMed ID: 38127692
[TBL] [Abstract][Full Text] [Related]
8. Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura.
Thomsen AV; Al-Karagholi MA; Hougaard A; Ostrowski SR; Pedersen OB; Hansen TF; Ashina M
Cephalalgia; 2024 Mar; 44(3):3331024241237247. PubMed ID: 38501895
[TBL] [Abstract][Full Text] [Related]
9. Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries.
Al-Karagholi MA; Ghanizada H; Hansen JM; Skovgaard LT; Olesen J; Larsson HBW; Amin FM; Ashina M
Headache; 2019 Oct; 59(9):1468-1480. PubMed ID: 31535367
[TBL] [Abstract][Full Text] [Related]
10. Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial.
Kokoti L; Al-Karagholi MA; Zhuang ZA; Amirguliyev S; Amin FM; Ashina M
Cephalalgia; 2024 May; 44(5):3331024241248211. PubMed ID: 38729773
[TBL] [Abstract][Full Text] [Related]
11. ATP-Sensitive Potassium Channels in Migraine: Translational Findings and Therapeutic Potential.
Clement A; Guo S; Jansen-Olesen I; Christensen SL
Cells; 2022 Aug; 11(15):. PubMed ID: 35954249
[TBL] [Abstract][Full Text] [Related]
12. Induction of migraine-like headache, but not aura, by cilostazol in patients with migraine with aura.
Butt JH; Rostrup E; Hansen AS; Lambertsen KL; Kruuse C
Brain; 2018 Oct; 141(10):2943-2951. PubMed ID: 30137217
[TBL] [Abstract][Full Text] [Related]
13. Extracranial activation of ATP-sensitive potassium channels induces vasodilation without nociceptive effects.
Al-Karagholi MA; Ghanizada H; Hansen JM; Aghazadeh S; Skovgaard LT; Olesen J; Ashina M
Cephalalgia; 2019 Dec; 39(14):1789-1797. PubMed ID: 31696739
[TBL] [Abstract][Full Text] [Related]
14. The headache and aura-inducing effects of sildenafil in patients with migraine with aura.
Butt JH; S Eddelien H; Kruuse C
Cephalalgia; 2022 Sep; 42(10):984-992. PubMed ID: 35332812
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Endothelin-1 Infusion Does Not Induce Aura or Headache in Migraine Patients With Aura.
Hougaard A; Younis S; Iljazi A; Sugimoto K; Ayata C; Ashina M
Headache; 2020 Apr; 60(4):724-734. PubMed ID: 31994720
[TBL] [Abstract][Full Text] [Related]
16. Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine.
Al-Karagholi MA; Ghanizada H; Waldorff Nielsen CA; Skandarioon C; Snellman J; Lopez-Lopez C; Hansen JM; Ashina M
Pain; 2021 Oct; 162(10):2512-2520. PubMed ID: 34252916
[TBL] [Abstract][Full Text] [Related]
17. PACAP38 induces migraine-like attacks in patients with migraine without aura.
Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M
Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between CSD-Evoked Metabolic Perturbations and Meningeal Afferent Activation and Sensitization: Implications for Mechanisms of Migraine Headache Onset.
Zhao J; Levy D
J Neurosci; 2018 May; 38(22):5053-5066. PubMed ID: 29703787
[TBL] [Abstract][Full Text] [Related]
19. Latest Insights into the Pathophysiology of Migraine: the ATP-Sensitive Potassium Channels.
Kokoti L; Al-Karagholi MA; Ashina M
Curr Pain Headache Rep; 2020 Dec; 24(12):77. PubMed ID: 33270149
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models.
Christensen SL; Rasmussen RH; Cour S; Ernstsen C; Hansen TF; Kogelman LJ; Lauritzen SP; Guzaite G; Styrishave B; Janfelt C; Christensen ST; Aziz Q; Tinker A; Jansen-Olesen I; Olesen J; Kristensen DM
Cephalalgia; 2022 Feb; 42(2):93-107. PubMed ID: 34816764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
